ANVS Annovis Bio Corporation Yalpi foyda marjasi

ANVS (Annovis Bio Inc) - kompaniyaning tovar belgisi

Annovis Bio, Inc. (ANVS) rahbariyati demensiya va tremor terapiyasi uchun ulkan va hali o'zlashtirilmagan bozorga yo'l ochishni maqsad qilgan. Nisbiy yalpi foyda ushbu strategiyaning natijalarini aks ettiradi, bunda 0.00 qiymati ushbu darajani xarakterlaydi. Turli tashxislar uchun dori vositalarini ishlab chiqish klinik risklarni minimallashtiradi, neyrodegeneratsiya uchun universal davolash usulini yaratish esa potentsial iste'molchilar va maqsadli bozorlarning qamrovini kengaytiradi.

ANVS (Annovis Bio) Yalpi marja tarixi 04.07.2022dan 20.11.2026gacha

annovisbio.com (ANVS) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning jamlanma tahlili:ANVS - Annovis Bio
Annovis Bio, Inc. brendining mahsuloti

Annovis Bio, Inc. (ANVS) kompaniyasining uzoq muddatli barqarorligini baholash uchun yalpi foyda marjasini — tushumning bevosita ishlab chiqarish xarajatlari chegirib tashlangan qismini — tahlil qilish muhimdir, bu esa tarixiy yalpi foyda marjasiga operatsion faoliyatdagi mavsumiy tebranishlarni filtrlash imkonini beradi. Ushbu ko'rsatkichning barqarorligi R&D yadrosining samarali boshqarilishini tasdiqlaydi, bunda yetakchi neyrobiologlarning saqlab qolinishi va ularning aksiyalar opsionlari orqali rag'batlantirilishi klinik sinovlarning kengayishi davrida ishga qabul qilish xarajatlarini minimallashtiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)